van Rhijn BWG - Search Results

1

Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy.

Claps F, Rai S, Mir MC, van Rhijn BWG, Mazzon G, Davis LE, Valadon CL, Silvestri T, Rizzo M, Ankem M, Liguori G, Celia A, Trombetta C, Pavan N. Claps F, et al. Among authors: van rhijn bwg. Urol Oncol. 2021 Dec;39(12):835.e9-835.e17. doi: 10.1016/j.urolonc.2021.04.026. Epub 2021 May 26. Urol Oncol. 2021. PMID: 34049782

2

BCAN Think Tank session 1: Overview of risks for and causes of bladder cancer.

Zlotta AR, Cohen SM, Dinney C, Droller M, van der Kwast TH, van Rhijn BW, Bochner B, Ameil G, Jewett MA. Zlotta AR, et al. Urol Oncol. 2010 May-Jun;28(3):329-33. doi: 10.1016/j.urolonc.2009.10.011. Urol Oncol. 2010. PMID: 20439032

3

Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome.

Mir MC, Trilla E, de Torres IM, Panizo A, Zlotta AR, Van Rhijn B, Morote J. Mir MC, et al. BJU Int. 2011 Jul;108(2 Pt 2):E71-6. doi: 10.1111/j.1464-410X.2010.09818.x. Epub 2010 Nov 10. BJU Int. 2011. PMID: 21070573

4

Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes.

Meijer RP, Nunnink CJ, Wassenaar AE, Bex A, van der Poel HG, van Rhijn BW, Meinhardt W, Horenblas S. Meijer RP, et al. J Urol. 2012 Feb;187(2):446-50. doi: 10.1016/j.juro.2011.10.029. Epub 2011 Dec 15. J Urol. 2012. PMID: 22177147

5

Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.

Turker P, Bostrom PJ, Wroclawski ML, van Rhijn B, Kortekangas H, Kuk C, Mirtti T, Fleshner NE, Jewett MA, Finelli A, Kwast TV, Evans A, Sweet J, Laato M, Zlotta AR. Turker P, et al. BJU Int. 2012 Sep;110(6):804-11. doi: 10.1111/j.1464-410X.2012.10939.x. Epub 2012 Feb 9. BJU Int. 2012. PMID: 22321341

6

Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer.

van Rhijn BW. van Rhijn BW. Urol Oncol. 2012 Jul-Aug;30(4):518-23. doi: 10.1016/j.urolonc.2012.04.002. Urol Oncol. 2012. PMID: 22742564 Review.

7

Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?

Mertens LS, Meijer RP, Kerst JM, Bergman AM, van Tinteren H, van Rhijn BW, Horenblas S. Mertens LS, et al. J Urol. 2012 Oct;188(4):1108-13. doi: 10.1016/j.juro.2012.06.018. Epub 2012 Aug 15. J Urol. 2012. PMID: 22901581

8

Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder.

Meijer RP, Meinhardt W, van der Poel HG, van Rhijn BW, Kerst JM, Pos FJ, Horenblas S, Bex A. Meijer RP, et al. Int J Urol. 2013 Aug;20(8):778-84. doi: 10.1111/iju.12038. Epub 2012 Dec 11. Int J Urol. 2013. PMID: 23231456

9

Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experience.

Meijer RP, Nieuwenhuijzen JA, Meinhardt W, Bex A, van der Poel HG, van Rhijn BW, Kerst JM, Bergman AM, van Werkhoven E, Horenblas S. Meijer RP, et al. Eur J Surg Oncol. 2013 Apr;39(4):365-71. doi: 10.1016/j.ejso.2013.01.003. Epub 2013 Jan 31. Eur J Surg Oncol. 2013. PMID: 23375648

10

Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone.

Mertens LS, Meijer RP, Meinhardt W, van der Poel HG, Bex A, Kerst JM, van der Heijden MS, Bergman AM, Horenblas S, van Rhijn BW. Mertens LS, et al. BJU Int. 2014 Jul;114(1):67-74. doi: 10.1111/bju.12447. Epub 2014 Jan 17. BJU Int. 2014. PMID: 24053889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters